Evidence map›Paper›PMID 15160287›Full record

ArticleParasitology research2004

Tegumental surface changes in adult Fasciola hepatica following treatment in vitro and in vivo with an experimental fasciolicide.

Norma Rivera, Froylán Ibarra, Armando Zepeda, Teresa Fortoul, Alicia Hernández, Rafael Castillo, Germinal Cantó

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. 5-Chloro-2-methyl-sulfanyl-6-(naphtha-len-1-yl-oxy)-1H-benzimidazole methanol monosolvate.Acta crystallographica. Section E, Structure reports online · 2014
    Article
  3. Article
  4. Potentilla fulgens (Family Rosaceae), a medicinal plant of north-east India: a natural anthelmintic?Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2010
    Article
  5. Anthelmintic efficacy of ethanolic shoot extract of Alpinia nigra on tegumental enzymes of Fasciolopsis buski, a giant intestinal parasite.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2009
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Norma RiveraFacultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Mexico City, Mexico. normariv@hotmail.com
Froylán Ibarra
Armando Zepeda
Teresa Fortoul
Alicia Hernández
Rafael Castillo
Germinal Cantó

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our objective was to determine by scanning electron microscopy the structural changes in the tegument of adult Fasciola hepatica after treatment with 5-chloro-2-methylthio-6-(1-naphtyloxy)-1 H-benzimidazole, called compound alpha, and its active metabolite sulphoxide, under in vitro and in vivo conditions. For the in vitro studies, flukes from sheep were exposed to 40 mg/l of compound alpha-sulphoxide over different incubation times. Flukes for the in vivo studies were raised in sheep treated orally with compound alpha and killed at different times post-treatment. Non-treated controls were included for each time of incubation. The results showed lesions after 6 h of treatment, such as swelling and furrows. At 12 h, the spines appeared to be surrounded by the tegument. At 24 h the tegument in some areas showed an exposed basal lamina. These changes became more severe as the incubation periods of the treated flukes increased. Compound alpha exerts a significant effect on the tegument of F. hepatica.

Indexed as

AnthelminticsImidazolesNaphthalenesAnimalsEpidermisFasciola hepaticaFascioliasisMaleMicroscopy, Electron, ScanningSheep DiseasesSulfoxides5-chloro-2-methylthio-6-(1-naphthyloxy)-1H-benzimidazoleAnthelminticsImidazolesNaphthalenesSulfoxides

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.